Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...
British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...
Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...
Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...
For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive ...
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
The Associated Press on MSN9d
Could obesity drugs help with alcohol cravings? New study suggests potentialA new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of ...
In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results